Organizations wishing to receive City Council funding in FY 2022 must complete Discretionary Funding application by February 19, 2021.
NYC Council established the Viral Hepatitis Initiative in 2014, to fund community organizations to provide hepatitis B and C prevention, linkage to care and care services.
NYS Medicaid FFS removed prior authorizations for first time direct acting antivirals (DAAs) treatment of Hep C infection and for re-treatment within one year for any reason.
The Hepatitis A, B and C in NYC: 2019 Annual Report provides the latest surveillance and programmatic data on viral hepatitis in NYC.
The NYS Viral Hepatitis Strategic Plan outlines a coordinated, comprehensive, and systematic approach that will decrease the incidence and reduce the morbidity and mortality of viral hepatitis.
In response to the COVID-19 pandemic, CMS expanded payment for telehealth services so that Medicare beneficiaries can get convenient and high-quality care from the comfort of their home while avoiding unnecessary exposure to the COVID-19 virus. CMS is now reviewing the temporary ...
Opportunity to comment on letter by a group of clinical providers working to promote policy changes that have the potential to improve capacity to treat hepatitis C in Opioid Treatment Programs in New York State.
Send an email to your New York City Council Member to ask them to refund the Viral Hepatitis Initiative in FY21!
The NYS Department of Health’s, AIDS Institute is hosting a series of community calls to allow an opportunity for comments and feedback on the completed preliminary recommendations for hepatitis C elimination in NYS and now we need your input!
The New York City Health Department’s Division of Disease Control invites interested New Yorkers to apply to be a member of its Transgender, Gender Non‐Conforming, and Non‐Binary (TGNCNB) Community Advisory Board, or TCAB. This advisory board is open to the public with a ...
